Marval O’Farrell Mairal advised Takeda on the transaction Takeda Pharmaceutical Company Limited (TSE:4502/NYSE:TAK) has entered into an agreement to divest a selection of non-core products from the...
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here